What are Key Factors Fuelling Surge of Global Automotive Human-Machine Interface Market?

The increasing demand for higher safety features and enhanced user experience in vehicles is one of the major factors pushing the adoption of automotive human–machine interface (HMI) across the world. Since the last few years, there has been a surge in the popularity of various advanced driver assistance systems (ADAS), such as automatic brakes and alert systems, which apprise drivers about the permissible speed limit, traffic situation, and traffic signals, which have, in turn, increased the demand for automative HMI. These HMI systems enhance the interaction between drivers and ADAS systems, thereby leading to better safety of the vehicle and passengers.

Due to the above-mentioned factors, the global automotive human–machine interface (HMI) market is expected to grow from $13.9 billion in 2017 to $29.6 billion by 2023, exhibiting a CAGR of 13.8% during the forecast period (2018–2023). The various types of automotive HMI systems available in the market are steering-mounted controls, touch screen displays, rear-seat entertainment (RSE) consoles, heads-up displays (HUD), instrument clusters, and multi-function switches. Amongst these, HUDs are expected to witness the fastest rise in procurement, owing to the increasing uptake of premium cars.

Request for sample copy of this report@ https://bit.ly/3ct84mN

The automotive HMI market is presently witnessing rapid technological developments, aimed at improving the consumer convenience level. Some of the improvements that have been made in these systems are the development of highly adaptable and dynamic displays and enhanced dashboard layout flexibilities. The soaring government incentives and other measures and increasing adoption of these systems are bolstering the scope for further advancements in them, with each passing year.

Geographically, the highest adoption of automotive HMI systems was observed in the Asia-Pacific (APAC) region in the past few years. This is primarily attributed to the higher sales of passenger cars in this region than anywhere else, on account of the surging purchasing power of the people. Owing to the burgeoning sales of premium and luxury cars and soaring customer preference for vehicles equipped with HMI features in the U.S., North America is expected to witness the fastest growth in the demand for automotive HMI systems during the forecast period.

Therefore, it is clear that due to the increasing adoption of ADAS in vehicles, soaring government initiatives, and growing need for enhanced safety systems in vehicles, the demand for automotive HMI systems will grow considerably in the coming years.

Read More: https://www.psmarketresearch.com/market-analysis/automotive-hmi-market

Read More

How is Rising Prevalence of Hospital-Acquired Infections Driving Hospital Infection Therapeutics Market?

Hospitals or other medical facilities are particularly associated with the treatment of diseases and the idea of getting infected with a pathogen while being in the hospitals may be quite foreign to a lot of people. However, hospital infections or hospital-acquired infections affect a lot of people; for example, according to the World Health Organization, of every 100 patients that are hospitalized, at any given time, about 10 in developing and 7 in developed counties will acquire at least one hospital infection. In addition to this, newborns especially are at a higher risk of suffering from healthcare associated disease in emerging economies.

Request for sample copy of this report@ http://bit.ly/2AXVcpy

Some of the hospital infections are catheter-associated urinary tract infections, central line-associated blood stream infections, hospital-acquired pneumonia, surgical site infections, Clostridium difficile infections, and ventilator-associated pneumonia. Much like any other infection, the risk of hospital infections depends on the patient’s immune status. Other than this, prevalence of several pathogens in the local community and infection control practices are also major factors on which hospital infection depend. Some of the major risk factors for these infections include longer hospital stays, older age, multiple underlying chronic illnesses, recent invasive procedures, immunosuppression, frequent encounters with healthcare facilities, and mechanical ventilatory support.

Because of these reasons, the need for preventing and treating hospital infections is growing, which is why the hospital infection therapeutics market is expected to register substantial growth in the coming years. Hospital infections are caused by viral, bacterial, and fungal pathogens, due to which a number of antiviral, antibacterial, and antifungal drugs have been developed. Among these, the largest demand is predicted to be created for antibacterial drugs in the near future. Pneumonia was the most prevalent hospital infection in the past and the prevalence of hospital acquired urinary tract infection is also projected to grow considerably in the coming years.

Geographically, North America has emerged as the largest hospital infection therapeutics market in the past few years, which is attributed to the enhanced healthcare infrastructure, increased awareness regarding healthcare, high ratio of hospitals in comparison to the population, surging aging population, and rising count of multi drug resistant microbial pathogens in the region. Apart from this, the demand for hospital infection therapeutics is also expected to increase significantly in the Asia-Pacific region because of the rising incidence of hospital infections and high requirement for therapeutic drugs in countries including China and India.

In conclusion, the demand for hospital infection therapeutics is growing due to the rising incidence of hospital infections.

Read more: https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market

Read More